top
Search terms
Results 1 - 10 of 45 - ordered by :
Pages: 1 2 3 4 5 ... 5
ESC365

Ischemic and bleeding events during dual antiplatelet therapy after second-generation drug-eluting stent implantation in hemodialysis patients: a propensity score-matched analysis

Date : 03/09/2019
Escardio

Genotype-guided oral P2Y12 inhibition reduces bleeding without raising clotting risk in heart attack patients undergoing stent implantation, according to late breaking results from the POPular ...

Date : 03/09/2019
Escardio

Bleeding during the first six months after discharge from hospital for a heart attack is linked with a subsequent cancer diagnosis, according to research presented today at ESC Congress 2019 together ...

Date : 31/08/2019
Ehjournal

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized ...

European Heart Journal, Golwala, Harsh B, Cannon, Christopher P, Steg, Ph Gabriel, Doros, Gheorghe, Qamar, Arman, Ellis, Stephen G, Oldgren, Jonas, ten Berg, Jurrien M, Kimura, Takeshi, Hohnloser, ...

Date : 14/05/2018 Item size : 4411 bytes
Ehjournal

Thrombus formation is a crucial event in acute coronary syndromes,1 bypass occlusion,2 and stent thrombosis.3 In the coronary circulation, platelet activation is an initial event,4 while expression ...

European Heart Journal, Lüscher, Thomas F

Date : 14/01/2018 Item size : 181767 bytes
Ehjournal

The recommended duration of 1year of dual antiplatelet therapy (DAPT) after an ACS is arbitrarily based on the treatment duration in the Clopidogrel in Unstable Angina to Prevent Recurrent Events ...

European Heart Journal, Sinnaeve, Peter R., Van de Werf, Frans

Date : 01/11/2017 Item size : 4411 bytes
Ehjournal

Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor (clopidogrel, prasugrel, or ticagrelor) is currently recommended following ACS for 1 year.1,2 Compared with clopidogrel, prasugrel, ...

European Heart Journal, Cuisset, Thomas, Deharo, Pierre, Quilici, Jacques, Johnson, Thomas W., Deffarges, Stéphanie, Bassez, Clémence, Bonnet, Guillaume, Fourcade, Laurent, Mouret, Jean ...

Date : 01/11/2017 Item size : 4411 bytes
Ehjournal

Introduction Among patients who survived a year since their last acute myocardial infarction (MI), subsequent major cardiovascular events, all-cause mortality and major bleeding risks are high.1,2 In ...

European Heart Journal, Pasea, Laura, Chung, Sheng-Chia, Pujades-Rodriguez, Mar, Moayyeri, Alireza, Denaxas, Spiros, Fox, Keith A.A., Wallentin, Lars, Pocock, Stuart J., Timmis, Adam, Banerjee, ...

Date : 07/04/2017 Item size : 349243 bytes
Ehjournal

Introduction Among patients who survived a year since their last acute myocardial infarction (MI), subsequent major cardiovascular events, all-cause mortality and major bleeding risks are high.1,2 In ...

European Heart Journal, Pasea, Laura, Chung, Sheng-Chia, Pujades-Rodriguez, Mar, Moayyeri, Alireza, Denaxas, Spiros, Fox, Keith A.A., Wallentin, Lars, Pocock, Stuart J., Timmis, Adam, Banerjee, ...

Date : 07/04/2017
Ehjournal

[...]RCTs include only relatively selected patients, raising concerns on the generalizability of the results to routine clinical practice.1 Moreover, even for therapies with well-established clinical ...

European Heart Journal, Alfonso, Fernando, Jiménez-Borreguero, Luis Jesús

Date : 07/04/2017 Item size : 216911 bytes